Sodium Benzoate
E211
The workhorse acid-food preservative — safe at intake limits, with a benzene caveat.
Moderate evidence
🍬Sweeteners & Additives
Evidence tier
Moderate
Research weight
Citations
10 verified / 10
Classification
Sweeteners & Additives
❝
What the evidence says. Several controlled trials; effects real but modest or context-dependent.
What is Sodium Benzoate?
Sodium Benzoate (E211) is a sweetener or food additive used for prevents spoilage by yeasts, molds and bacteria in acidic foods. NutriDex grades the human evidence as Moderate. Sodium benzoate (E211) is the sodium salt of benzoic acid, one of the oldest and most widely used antimicrobial preservatives. It works only in acidic foods (pH below ~4.5), so it appears mainly in soft drinks, fruit juices, pickles, salad dressings, condiments and acidic sauces, as well as in some pharmaceuticals and cosmetics. It is FDA GRAS, EU-approved, and JECFA-evaluated; regulators consistently conclude it is not genotoxic or carcinogenic at permitted levels. The main real-world concern is not benzoate itself but benzene, a known carcinogen that can form in trace amounts when benzoate and ascorbic acid (vitamin C) coexist in beverages exposed to heat and light.
Purported Benefits
✓Prevents spoilage by yeasts, molds and bacteria in acidic foods
✓Highly effective at low pH (below ~4.5)
✓Highly water-soluble, so easy to formulate in beverages
✓Inexpensive and stable, extends shelf life
✓Also used as a pharmaceutical excipient and, at gram doses, as an investigational add-on therapy for schizophrenia (D-amino acid oxidase inhibition)
Dosing & Compounds
Typical Dose
FDA GRAS as a direct food substance (21 CFR 184.1733), used at up to ~0.1% in food. JECFA group ADI revised in 2021 to 0–20 mg/kg bw/day (expressed as benzoic acid; up from the prior 0–5 mg/kg), covering benzoic acid and its calcium/potassium/sodium salts. EFSA's 2016 re-evaluation derived a more conservative ADI of 5 mg/kg bw/day and flagged that high-consuming toddlers and children could exceed the group ADI from flavored drinks.
Active Compounds
Safety & Cautions
At permitted intakes, regulators (EFSA 2016, JECFA 2021, FDA GRAS) find no genotoxicity or carcinogenicity concern; benzoate is rapidly conjugated with glycine to hippuric acid and excreted in urine. The principal documented hazard is chemical: benzene (an IARC Group 1 human carcinogen) can form at low ppb levels when sodium benzoate and ascorbic acid co-occur in beverages exposed to heat/light — FDA testing (2005–2007) found a small number of drinks above the 5 ppb drinking-water limit, and manufacturers reformulated. A 2016 EFSA exposure analysis warned high-consuming toddlers/children may exceed the ADI. A pilot study linked sodium-benzoate-rich beverage intake to self-reported ADHD symptoms in college students (association only, confounded by sugar/caffeine). Benzoates can occasionally trigger non-allergic intolerance reactions (urticaria, asthma exacerbation) in sensitive individuals. Caveat: gram-dose therapeutic use studied in schizophrenia is hundreds of times higher than dietary exposure and is not relevant to food-additive safety. Educational only — always check with your doctor or pharmacist before combining Sodium Benzoate with any medicine.
Key Studies ★ 10 studies
Systematic review and meta-analysis
Liang et al. 2024
✓ PubMed
Across 10 trials in neuropsychiatric disorders, adjunctive sodium benzoate produced a small-to-moderate improvement in global cognitive function versus placebo (SMD 0.40, 95% CI 0.20-0.60, rated high certainty).
Meta-analysis of double-blind RCTs
Chang et al. 2025
✓ PubMed
In a meta-analysis of double-blind RCTs (four of five trials used sodium benzoate), DAAO inhibitors reduced total PANSS symptoms (SMD -0.27) and improved cognition (SMD 0.36) in schizophrenia, with significant effects in the sodium benzoate subgroup.
Regulatory
US FDA 21 CFR 184.1733
✓ Source
Affirms sodium benzoate as Generally Recognized As Safe (GRAS) as an antimicrobial and flavoring agent, consistent with use at a maximum of about 0.1% in food.
Regulatory assessment
JECFA 2021 (92nd meeting)
✓ Source
Established a revised group ADI of 0–20 mg/kg bw/day for benzoic acid and its salts (expressed as benzoic acid equivalents), withdrawing the previous 0–5 mg/kg ADI after applying a chemical-specific toxicokinetic adjustment factor.
Regulatory assessment
EFSA ANS Panel 2016
✓ Source
Re-evaluation concluded no genotoxic or carcinogenic concern and derived an ADI of 5 mg/kg bw/day (as benzoic acid), but found high-level toddler/child consumers of flavored drinks could exceed the group ADI.
Regulatory / contaminant assessment
US FDA (Benzene in beverages Q&A)
✓ Source
In the presence of ascorbic acid and under heat/light, benzoate can decarboxylate to form benzene; 2005–2007 testing of >200 beverages found a small number above the 5 ppb water standard, prompting reformulation.
RCT
Lin 2018 (Biol Psychiatry)
✓ PubMed
Double-blind RCT in clozapine-resistant schizophrenia (n=60) found add-on sodium benzoate (1–2 g/day) improved symptomatology vs placebo, supporting the DAAO-inhibition mechanism at gram doses.
RCT
Lane 2013 (JAMA Psychiatry)
✓ PubMed
Randomized double-blind placebo-controlled trial: 1 g/day add-on sodium benzoate (a D-amino acid oxidase inhibitor) improved PANSS symptom and cognitive scores in chronic schizophrenia — a pharmacologic dose far above dietary exposure.
Authoritative assessment
Walker / IARC benzene classification
✓ Source
Benzene is classified by IARC as a Group 1 carcinogen (causally linked to leukemia), which is why trace benzene formation in benzoate-plus-vitamin-C beverages is treated as a contaminant concern even though benzoate itself is not carcinogenic.
Cross-sectional study
Beezhold 2014 (J Atten Disord)
✓ PubMed
Cross-sectional survey of 475 college students found sodium-benzoate-rich beverage intake associated with higher ADHD symptom scores (p=.001); high-symptom students reported ~35 vs ~17 servings/month — association only, hypothesis-generating.